Sign up to save your podcasts
Or
Share LAMA (Long-Acting Muscarinic Antagonists) Bronchodilators for COPD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
LAMA (Long-Acting Muscarinic Antagonists) Bronchodilators for COPD
In this lecture from This is Why, Dr. Busti will explain the COPD maintenance inhalers you’ll actually see in practice. In this pharmacology review, we break down LAMA (long-acting muscarinic antagonist) bronchodilators—one of the most important bronchodilator classes for COPD treatment—so you can confidently understand the drugs, the mechanism, and the real-world clinical use.
You’ll learn how to:
- What LAMA / antimuscarinic bronchodilators are and how they work
- Where LAMA inhalers fit in COPD therapy and long-term symptom control
- Key differences and practical pearls for common COPD inhalers
- High-yield side effects, contraindications, and patient counseling points
- How to recognize and avoid common med errors and confusion with inhaler names/classes
Drugs covered:
- Tiotropium (Spiriva)
- Umeclidinium (Incruse Ellipta)
- Aclidinium (Tudorza Pressair)
- Glycopyrrolate (COPD maintenance formulations)
The goal = make medical education easy and clinically relevant.
Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/lama-bronchodilators-copd-tiopotropium-umeclidinium-pharmacology
Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources
If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.
Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!
Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.
View all episodes
By Anthony Busti, MD, PharmD, MSc, FNLA, FAHAIn this lecture from This is Why, Dr. Busti will explain the COPD maintenance inhalers you’ll actually see in practice. In this pharmacology review, we break down LAMA (long-acting muscarinic antagonist) bronchodilators—one of the most important bronchodilator classes for COPD treatment—so you can confidently understand the drugs, the mechanism, and the real-world clinical use.
You’ll learn how to:
- What LAMA / antimuscarinic bronchodilators are and how they work
- Where LAMA inhalers fit in COPD therapy and long-term symptom control
- Key differences and practical pearls for common COPD inhalers
- High-yield side effects, contraindications, and patient counseling points
- How to recognize and avoid common med errors and confusion with inhaler names/classes
Drugs covered:
- Tiotropium (Spiriva)
- Umeclidinium (Incruse Ellipta)
- Aclidinium (Tudorza Pressair)
- Glycopyrrolate (COPD maintenance formulations)
The goal = make medical education easy and clinically relevant.
Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/lama-bronchodilators-copd-tiopotropium-umeclidinium-pharmacology
Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources
If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.
Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!
Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.